

Drug Class: Growth Hormone Fragment
Composition: AOD9604
Dosage: 5 mg/vial
Form: Lyophilized Powder
Unit: 2 mL Multidose Vial
Brand: Dragon Pharma
For Subcutaneous Injection
Dragon Pharma AOD 9604 is a potent fat-burning peptide derived from the C-terminus of human growth hormone (HGH), specifically designed to stimulate lipolysis and inhibit lipogenesis without affecting insulin or IGF-1 levels. Each 2 mL vial contains 5 mg of AOD 9604, ideal for subcutaneous administration during cutting and body recomposition phases.
AOD 9604 (Advanced Obesity Drug) is a synthetic peptide fragment of HGH (specifically amino acids 176–191) that mimics the fat-burning effects of HGH without the associated side effects such as water retention, insulin resistance, or growth of lean tissue. Clinical studies such as those published by the National Institutes of Health show that AOD 9604 enhances fat metabolism and may improve recovery and joint health in active populations.
AOD 9604 is often used by physique athletes, older individuals, or those seeking safe fat loss support without the complications of full HGH cycles.
Typical dosages range from 300 to 500 mcg per day, injected subcutaneously, ideally on an empty stomach. AOD 9604 may be taken once or twice daily (AM and pre-bed), and cycle duration ranges from 4 to 12 weeks depending on goals.
Dragon Pharma's AOD 9604 is produced in GMP-certified labs, with each batch tested for potency and microbial purity to ensure consistent results and user safety.
For enhanced results, AOD 9604 is often stacked with:
AOD 9604 is well-tolerated and does not exhibit the side effects commonly associated with anabolic agents or full-length growth hormone. Rare reports may include localized injection-site irritation or mild fatigue during adjustment.
Dragon Pharma is known for quality assurance, lab-verified ingredients, and reliable shipping throughout the USA. Our AOD 9604 5 mg vials offer a precise fat-loss solution trusted by athletes, physique competitors, and health-conscious users alike.
Explore more performance and recovery-enhancing products in the Dragon Pharma USA catalog.
Name: AOD 9604
Drug Class: Growth Hormone Fragment, Peptide
Other common names and terms: Advanced Obesity Drug 9604, GH Frag 176-191
Active Life: A few hours
Detection Time: Approximately 24 hours
Chemical Structure: Modified fragment of Human Growth Hormone (amino acids 176-191)
Common Doses: 250-1000 mcg per day, typically administered once daily
Blood pressure: No significant effect
Acne: No
Water retention: No
Aromatisation: No (does not convert to estrogen)
Liver toxicity: None reported
Decrease HPTA function: No
Yes. AOD 9604 has been shown to stimulate fat loss without impacting appetite or muscle mass, making it effective in cutting phases.
Results vary, but users typically notice fat loss and improved definition within 2–4 weeks of consistent use combined with diet and exercise.
Yes. AOD 9604 does not affect insulin levels or IGF-1 like full HGH, making it safer and more targeted for fat loss without growth-related side effects.
Yes. AOD 9604 works well with stimulants like Clenbuterol or ECA stacks, as it does not contain stimulants and won't overtax the CNS.
No. AOD 9604 does not suppress natural testosterone or hormone production, so post-cycle therapy is not necessary after use.
Please log in to write AOD 9604 5 mg review.
Drug Class: Recombinant Human Growth Hormone (rHGH)
Composition: Somatropin 191aa
Dosage: 10 IU/vial
Form: Lyophilized Powder
Unit: 1 Kit (10 x 2 mL Vials)
Brand: Dragon Pharma
Laboratory Test: View Latest Lab Report
For Injectable Use After Reconstitution
Drug Class: Gonadotropin, Fertility Agent
Composition: Human Chorionic Gonadotropin (HCG)
Dosage: 2500 IU/vial
Form: Lyophilized Powder
Unit: 2 mL Multidose Vial + 1 Amp Solvent
Brand: Dragon Pharma
Laboratory Test: View Lab Report
For Injectable Use After Reconstitution
Drug Class: Synthetic Peptide (Thymosin Beta-4)
Composition: Thymosin Beta-4
Dosage: 5 mg/vial
Form: Lyophilized Powder
Unit: 2 mL Vial
Brand: Dragon Pharma
Laboratory Test: View Lab Report
For Subcutaneous Injection After Reconstitution
Drug Class: Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist
Composition: Semaglutide
Dosage: 5 mg/vial
Form: Lyophilized Powder
Unit: 2 mL Vial
Brand: Dragon Pharma
Laboratory Test: View Lab Report
For Subcutaneous Injection After Reconstitution
Drug Class: Gonadotropin, Fertility Agent, LH Analog
Composition: Human Chorionic Gonadotropin
Dosage: 5000 IUs/vial
Form: Lyophilized Powder
Unit: 2 mL Vial + 1 Amp Solvent
Brand: Dragon Pharma
Laboratory Test: View Lab Report
For Subcutaneous Injection
Drug Class: Dual GIP and GLP-1 Receptor Agonist
Composition: Tirzepatide
Dosage: 5 mg/vial
Form: Lyophilized Powder
Unit: 2 mL Vial
Brand: Dragon Pharma
Laboratory Test: View Lab Report
For Subcutaneous Injection
Drug Class: Synthetic Melanocortin Agonist Peptide
Composition: Melanotan II
Dosage: 10 mg/vial
Form: Lyophilized Powder
Unit: 2 mL Vial
Brand: Dragon Pharma
Laboratory Test: View Lab Report
For Injectable Use After Reconstitution
Drug Class: Anxiolytic Nootropic Peptide
Composition: Selank
Dosage: 10 mg/vial
Form: Lyophilized Powder
Unit: 2 mL Vial
Brand: Dragon Pharma
Laboratory Test: View Lab Report
For Injectable & Intranasal Use After Reconstitution